Intuitive Surgical teams with Chinese company on lung cancer
03-Oct-16, MD + DI
Intuitive Surgical is expanding into robotic-assisted catheter-based medical devices through a joint venture with Shanghai Fosun Pharmaceutical. At the outset, these devices, which will use proprietary intellectual property from Intuitive Surgical, will be focused on diagnosis and treatment of lung cancer.
%20Asian%20Scientist%20Magazine.jpg "Intuitive Surgical teams with Chinese company on lung cancer (c) Asian Scientist Magazine")
Image: Asian Scientist Magazine
Intuitive Surgical has had a relationship with Fosun Pharma in the past, as Fosun subsidiary Chindex Medical Limited is a Chinese distribution partner for Intuitive's da Vinci Surgical Systems.The two companies will put up to $100 million into the joint venture.
Research and development and manufacturing will take place in Shanghai. Intuitive Surgical will oversee distribution of any devices outside of China while the joint venture will be in charge of distribution within China.